An inactivated BVD vaccine for cows and heifers to protect the foetus against transplacental infection with bovine viral diarrhoea virus (BVDV). Can be mixed and administered with Bovilis IBR marker live, or administered with Leptavoid®-H; see Leptavoid H datasheet for more information.
Suspension for injection
Each dose of 2 ml contains: Inactivated cytopathogenic bovine viral diarrhoea (BVD) virus type 1 strain C-86, containing 50 ELISA Units (EU) and inducing at least 4.6 log2 VN units*
*Mean virus neutralizing titre obtained in the potency test
Indications for use
For active immunisation of cows and heifers from eight months of age onwards to protect the foetus against transplacental infection with BVDV.
Safety and efficacy data are available which demonstrate that for re-vaccination in cattle from 15 months of age onwards (i.e. those that have previously been vaccinated separately with Bovilis BVD and Bovilis IBR marker live) - this vaccine can be mixed and administered with Bovilis IBR marker live.
Cattle - milk 0 hours, meat 0 days
2 ml single dose or 10/20/50/100 or 250 ml multidose vial of glass, hydrolytical class Type I (Ph. Eur.) or polyethylene-terephthalate (PET) closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap. Not all pack sizes may be marketed.
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018